Status:
RECRUITING
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Inherited Metabolic Disorder of Nervous System
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Screening for sulfur amino acid metabolism pathologies using a sulfitest in adult patients with psychotic disorder.
Detailed Description
Psychotic disorder is a public health problem, with a cumulative incidence in the general population estimated at 3%. Although in most cases the origin is purely psychiatric, psychotic disorder can al...
Eligibility Criteria
Inclusion
- Male or female 18 years of age and older,
- Followed for a psychotic disorder,
- With no known organic etiology for the psychotic disorder,
- Not having formulated its opposition to participation in the study (or his/her tutor/curator),
- Affiliated with the social security system.
Exclusion
- Patients protected by law (minors, pregnant or breastfeeding women, deprived of liberty or hospitalized under constraint, under administrative or judicial supervision) except patients under tutorship or curatorship.
Key Trial Info
Start Date :
January 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05206292
Start Date
January 12 2023
End Date
June 1 2025
Last Update
June 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, France, 38043